OCRA Awards Millions in New Ovarian Cancer Research Grants

Despite the challenges of fundraising during a global pandemic, your generous support allowed us to fund 16 top scientists at 14 esteemed medical centers across the globe. They will investigate important issues across the ovarian cancer landscape in this coming year.

These grants enable the brightest minds in cancer research to tackle long-standing issues like ovarian cancer drug resistance, and to break new ground toward immunotherapy, precision medicine, combination treatments, genetic mutations, and more.

OCRA 2021 ovarian cancer research grantees

“OCRA is so proud, and grateful, to fund this new and promising group of investigators, all of whom are working to answer some of the most critical questions in ovarian cancer research today.

We are thrilled to support these groundbreaking projects, whose findings will further our understanding of this complicated disease, and bring us closer to a world where no one needs to fear an ovarian cancer diagnosis.”

Audra Moran, OCRA President & CEO

Collaborative Research Development Grant Recipients

Liz Tilberis Early Career Award Recipients

Ann and Sol Schreiber Mentored Investigator Award Recipients

These grants were made possible only because of direct support from you, our dedicated community. We thank you for your commitment to research that will save lives, and look forward to sharing more information on these cutting-edge projects, and the discoveries they yield, in the weeks and months ahead.

Posted on in OCRA News, Research